Session-aware quotes · provider delays vary · Not financial advice
BullishMEDIUM severityTech & AI24d ago

Veracyte outlines $590M-$596M 2026 revenue guidance while expanding Prosigna and TrueMRD launches

Reported by Seeking Alpha · seekingalpha.com · July 31, 2026

$VCYT
Bullish read

Veracyte (VCYT) Q2 2026 earnings call highlights: Prosigna/TrueMRD launches, raised revenue guidance, Decipher volume reset, risks & outlook—read now.

What the tape says

What to watch: VCYT (VCYT) raised guidance — confirm the raise reflects durable demand, not a one-time item.

Amount
$590 million
Amount
$596 million

Market reaction today: $VCYT -1.99%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.